Sangamo Therapeutics (SGMOQ) Deferred Taxes (2015 - 2025)

Sangamo Therapeutics (SGMOQ) posted quarterly Deferred Taxes of $15000.0 for Q1 2025, up 183.33% quarter-over-quarter from -$18000.0 in Q4 2024.

Sangamo Therapeutics (SGMOQ) Deferred Taxes (2015 - 2025) Analysis & Trends

Sangamo Therapeutics' Deferred Taxes history runs 5 years deep, the most recent figure standing at $15000.0 for Q1 2025.

In Q1 2025, Deferred Taxes changed N/A year-over-year to $15000.0; the TTM figure through Mar 2025 stood at $15000.0 (down 64.29% YoY), while the FY2023 annual figure was -$6.3 million, changed N/A from the prior year.
Deferred Taxes for Q1 2025 stood at $15000.0, up from -$18000.0 in the prior quarter.
The five-year high for Deferred Taxes was $182000.0 in Q3 2023, with the low at -$140000.0 in Q4 2023.
The 3-year median for Deferred Taxes is $15000.0 (2025), against an average of $11400.0.
Peak annual rise in Deferred Taxes reached 87.14% in 2024, while the deepest fall reached 90.11% in 2024.
Sangamo Therapeutics' Deferred Taxes stood at -$140000.0 in 2023, then jumped by 87.14% to -$18000.0 in 2024, then jumped by 183.33% to $15000.0 in 2025.
Business Quant data shows SGMOQ's Deferred Taxes at $15000.0 in Q1 2025, -$18000.0 in Q4 2024, and $18000.0 in Q3 2024.

Download Data